100 related articles for article (PubMed ID: 18757853)
1. ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia.
Reinoso-Martín C; Jantus-Lewintre E; Ballesteros CG; Campos CB; Ferrer JR; García-Conde J
Haematologica; 2008 Sep; 93(9):1422-4. PubMed ID: 18757853
[No Abstract] [Full Text] [Related]
2. Determining the clinical course and outcome in chronic lymphocytic leukemia.
Rai KR; Chiorazzi N
N Engl J Med; 2003 May; 348(18):1797-9. PubMed ID: 12724486
[No Abstract] [Full Text] [Related]
3. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
4. Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
Cajiao I; Sargent R; Elstrom R; Cooke NE; Bagg A; Liebhaber SA
Am J Hematol; 2007 Aug; 82(8):712-20. PubMed ID: 17315213
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
6. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
[TBL] [Abstract][Full Text] [Related]
7. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
10. ZAP-70 expression remains stable in chronic lymphocytic leukaemia.
Gibbs G; Bromidge T; Howe D; Johnson S
Int J Lab Hematol; 2007 Jun; 29(3):225-7. PubMed ID: 17474902
[No Abstract] [Full Text] [Related]
11. ZAP70 in chronic lymphocytic leukaemia.
Amin S; Parker A; Mann J
Int J Biochem Cell Biol; 2008; 40(9):1654-8. PubMed ID: 17625948
[TBL] [Abstract][Full Text] [Related]
12. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
13. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
15. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis.
Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M
Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585
[TBL] [Abstract][Full Text] [Related]
16. [Molecular biology of CLL].
Szepesi A
Magy Onkol; 2005; 49(4):327-30. PubMed ID: 16518477
[TBL] [Abstract][Full Text] [Related]
17. Genetic lesions in chronic lymphocytic leukemia: clinical implications.
Montserrat E; Moreno C
Curr Opin Oncol; 2009 Nov; 21(6):609-14. PubMed ID: 19713841
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.
Secchiero P; di Iasio MG; Gonelli A; Barbarotto E; Melloni E; Tiribelli M; Chiaruttini C; Zauli G
J Cell Physiol; 2007 Oct; 213(1):229-36. PubMed ID: 17476690
[TBL] [Abstract][Full Text] [Related]
19. Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease.
Smolej L; Vroblova V; Novosad J
Int J Lab Hematol; 2008 Jun; 30(3):259-60; author reply 260. PubMed ID: 18479306
[No Abstract] [Full Text] [Related]
20. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.
Chantepie SP; Vaur D; Grunau C; Salaün V; Briand M; Parienti JJ; Heutte N; Cheze S; Roussel M; Gauduchon P; Leporrier M; Krieger S
Leuk Res; 2010 Jun; 34(6):800-8. PubMed ID: 19944462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]